The Most Fascinating Findings After A Quarter Century of Science in the ISS

While aboard, astronauts have conducted thousands of studies, from tracking space’s effects on the human body to exploring ...
Le Lézard

Genentech to Present New Data From Its Broad and Innovative Hematology Portfolio at ASH 2025

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that it will showcase 46 abstracts, including 12 oral presentations, from its industry-leading hematology portfolio ...

GC Biopharma's Recombinant Anthrax Vaccine, BARYTHRAX, Demonstrates Safety and Immunogenicity in Phase 2 Data, Published in 'Vaccine'

GC Biopharma, a leading global pharmaceutical company based in South Korea, announced today that the Phase 2 c ...
TMCnet

TG Therapeutics Reports Third Quarter 2025 Financial Results and Raises BRIUMVI Revenue Guidance

NEW YORK, Nov. 03, 2025 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX) (the Company or TG Therapeutics) today announced its financial results for the third quarter of 2025, along with recent ...